References
- 1
Bharucha K J, Sethi K D.
Complex movements disorders induced by fluoxetine.
Movement Disorders.
1996;
11 (3)
324-326
- 2
Bird E D, Iverson L L.
Huntington’s chorea - postmortem measurement of glutamic acid decarboxylase, choline
acetyltransferase and dopamine in basal ganglia.
Brain.
1974;
97
457-472
- 3
Heathfield K WG.
Huntington’s chorea.
Brain.
1967;
90
203-232
- 4
Jimenez-Jimenez F J, Molina J A.
Extrapyramidal symptoms associated with selective serotonin reuptake inhibitors, epidemiology,
mechanisms and management.
CNS Drugs.
2000;
14 (5)
367-379
- 5 Lishman W A. Organic Psychiatry. Blackwell Science Oxford; 1998: 469-470
- 6
Myrianthopolous N C.
Huntington’s chorea.
J Med Gen.
1966;
3
298-314
- 7
Saxena S Brody A L, Schwart J M, Baxter L R.
Neuroimaging and frontal-subcortical circuitry in obsessive-compulsive disorder.
B J Psych.
1998;
173 (suppl 35)
26-37
- 8
Scicutella A.
Late-life obsessive-compulsive disorder and Huntington’s disease.
J Neuropsy Clin Neurosci.
2000;
12
228-289
- 9
Spokes E GS.
Neurochemical alterations in Huntington’s chorea: a study of post-mortem brain tissue.
Brain.
1980;
103
179-210
- 10
Wanker E E.
Protein aggregation in Huntington’s and Parkinson’s disease: implications for therapy.
Mol Med Today.
2000;
6 (10)
387-391
- 11 World Health Organisation (eds). The ICD - 10 classification of mental and behavioural
disorders. Geneva; WHO 1995
Dr. Suresh Chari
Specialist Registrar
The Caludon Centre
Clifford Bridge Road
Coventry CV2 2TE
UK
Phone: UK +24-7660 2020 x 7132
Fax: UK +24-7653 8920
Email: suresh.chari@ntlworld.com
